to move the epidemiology forward, we suggest using well-characterized cohorts of newly diagnosed als patients to identify risk and prognostic factors; storing biological material for future studies; building on the national als registry as a resource of future studies; working in multidisciplinary consortia; and addressing the possible early life etiology of als.